A composition comprising collagen and honey can be produced by addition of an aqueous solution of honey to an aqueous suspension of collagen. The composition is for use in medicine and particularly for use in the treatment of a wound. A method for treatment of a wound comprises administering the composition topically to the skin of a patient.

The present invention is directed to methods and compositions for treating, preventing, or minimizing bad breath in an animal, including administering compositions comprising honey and spirulina.

The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.

A cosmetic skin care product comprising a therapeutically effective amount of a honey extract is described, the honey extract having a phenolic compound to saccharides ratio of at least 5 times greater than the raw honey from which the extract is derived and including a mixture of at least ethanol, water and one or more MMP inhibitory phenolic compounds.

The present invention relation to an oral care composition comprising a cannabinoid and at least one pharmaceutical active component is provided in which the at least one pharmaceutical active component improves oral health beyond benefits provided by the at least one cannabinoid alone. The at least one pharmaceutical active component can be Manuka honey. The oral care composition can be used in an oral care product for whitening or bleaching teeth.

Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

Disclosed are propolis products suitable for use in various industries such as food, health and cosmetics where propolis, which promote various beneficial biological activities in addition to having antimicrobial, antifungal, antiviral, anti-inflammatory, anti-cancer and anesthetic affects, is extracted correctly to offer it a form suitable for human consumption and with the highest bioavailability, where it is fast and easy to consume. Also disclosed is a method of production thereof.

The present invention relation to an oral care composition comprising a cannabinoid and at least one pharmaceutical active component is provided in which the at least one pharmaceutical active component improves oral health beyond benefits provided by the at least one cannabinoid alone. The at least one pharmaceutical active component can be Manuka honey. The oral care composition can be used in an oral care product for whitening or bleaching teeth.

The invention relates to a cosmetic composition comprising royal jelly of the Ouessant black bee in a cosmetically acceptable medium, and to its use for regenerating and/or healing the skin.

A fermented pollen-based composition is provided which is made by treating pollen grains with one or more natural potassium sources selected from coconut water, coconut milk, raw honey, or honeydew honey, to naturally stimulate germination of the pollen, then incubating the germinated pollen, optionally with one or more additional components selected from beeswax, oils, enzyme-containing components derived from fruit, and probiotic components, wherein the resulting composition comprises a plurality of bioactive components selected from low molecular weight peptides, fatty acids, esterified flavonoids, dicaffeoyl quinic acid isomers and dicaffeoyl tartaric acid ester or ether compounds. Topical skin compositions including the fermented pollen-based composition as an active ingredient are also provided.